MedTrace Logo

ASR-XL Metal-on-Metal 522 Post-Market Surveillance Study

NCT01884532 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 146

Last updated 2016-09-26

No results posted yet for this study

Summary

The purpose of this clinical study is to evaluate blood metal ion levels as a function of time of implantation for the ASR-XL MoM system.

Conditions

  • Adverse Local Tissue Reaction
  • Total Hip Arthroplasty

Interventions

DEVICE

ASR-XL Metal-on-Metal

All patients that are post-operative will have undergone total hip arthroplasty with the ASR-XL Metal-on-Metal device.

Sponsors & Collaborators

  • DePuy Orthopaedics

    lead INDUSTRY

Principal Investigators

  • Mary F Panozzo, BS · DePuy Synthes Joint Reconstruction

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2015-06-30
Completion
2016-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01884532 on ClinicalTrials.gov